GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » EV-to-EBIT

Vicarious Surgical (Vicarious Surgical) EV-to-EBIT : 0.34 (As of May. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vicarious Surgical's Enterprise Value is $-21.01 Mil. Vicarious Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-61.13 Mil. Therefore, Vicarious Surgical's EV-to-EBIT for today is 0.34.

The historical rank and industry rank for Vicarious Surgical's EV-to-EBIT or its related term are showing as below:

RBOT' s EV-to-EBIT Range Over the Past 10 Years
Min: -280.07   Med: 0   Max: 63.47
Current: 0.34

During the past 4 years, the highest EV-to-EBIT of Vicarious Surgical was 63.47. The lowest was -280.07. And the median was 0.00.

RBOT's EV-to-EBIT is ranked better than
94.32% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.815 vs RBOT: 0.34

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Vicarious Surgical's Enterprise Value for the quarter that ended in Mar. 2024 was $-16.47 Mil. Vicarious Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-61.13 Mil. Vicarious Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 371.08%.


Vicarious Surgical EV-to-EBIT Historical Data

The historical data trend for Vicarious Surgical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical EV-to-EBIT Chart

Vicarious Surgical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- -31.32 28.70 0.27

Vicarious Surgical Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.20 -2.12 -0.12 0.27 0.27

Competitive Comparison of Vicarious Surgical's EV-to-EBIT

For the Medical Devices subindustry, Vicarious Surgical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicarious Surgical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vicarious Surgical's EV-to-EBIT falls into.



Vicarious Surgical EV-to-EBIT Calculation

Vicarious Surgical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-21.013/-61.126
=0.34

Vicarious Surgical's current Enterprise Value is $-21.01 Mil.
Vicarious Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-61.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicarious Surgical  (NYSE:RBOT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Vicarious Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-61.126/-16.4725075
=371.08 %

Vicarious Surgical's Enterprise Value for the quarter that ended in Mar. 2024 was $-16.47 Mil.
Vicarious Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-61.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicarious Surgical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicarious Surgical (Vicarious Surgical) Business Description

Traded in Other Exchanges
N/A
Address
78 Fourth Avenue, Waltham, MA, USA, 02451
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
Executives
William John Kelly officer: CFO and Treasurer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Adam David Sachs director, 10 percent owner, officer: President and CEO C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa director, 10 percent owner, officer: Chief Technology Officer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
June Morris officer: CLO, General Counsel and Sec C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola officer: Chief Operating Officer TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
Khosla Ventures Opportunity Associates Ii, Llc 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Ii, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho director UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang director C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr director C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss director C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
E15 Fund Ii, Lp other: Sole Shareholder C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Shrikant Patnaik other: Principal C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop director C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803